Does Hemoglobin E (HbE) trait, heterozygous, affect HbA1c (hemoglobin A1c) measurement or interpretation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Impact of Hemoglobin E Trait on HbA1c Measurement and Interpretation

Most assays used in the U.S. are accurate in individuals heterozygous for common hemoglobin variants, including Hemoglobin E trait, though clinicians should verify their specific assay method for potential interference. 1

Understanding HbA1c and Hemoglobin Variants

HbA1c is the primary tool for assessing glycemic control in diabetes management, reflecting average glycemia over approximately 2-3 months. However, certain factors can affect the accuracy of HbA1c measurements, including hemoglobin variants.

Hemoglobin E Trait and HbA1c Measurement:

  • Assay Accuracy: Most National Glycohemoglobin Standardization Program (NGSP)-certified assays used in the United States provide accurate results in individuals who are heterozygous for common hemoglobin variants, including HbE 1

  • Method-Specific Interference: The effect of HbE trait on HbA1c measurement varies by the specific laboratory method used:

    • Some assays show statistically significant interference but not clinically significant differences
    • Boronate affinity chromatography methods may be more reliable for patients with hemoglobin variants 2
  • Potential for Misinterpretation: When using certain high-performance liquid chromatography (HPLC) methods, HbE trait may result in undetectable or falsely low HbA1c values 3

Clinical Approach to HbA1c Interpretation with HbE Trait

When to Suspect Interference:

  • Discordant Results: Marked discrepancy between measured HbA1c and plasma glucose levels should raise suspicion of HbA1c assay interference 1

  • Microcytosis: MCV of 80fl or below may serve as a rough guide to identify samples that might have hemoglobin variants affecting HbA1c measurement 3

  • Unexpected Values: Unexpectedly low or undetectable HbA1c results despite elevated blood glucose levels 3

Management Algorithm:

  1. Verify assay method compatibility:

    • Check the NGSP website (www.ngsp.org/interf.asp) for updated information on which assays are affected by HbE trait 1
    • Consult with the laboratory to determine if their specific assay is known to have interference with HbE
  2. If interference is suspected:

    • Request an alternative assay method without interference with HbE trait 1
    • Consider using plasma glucose criteria for diagnosis instead 1
  3. Consider alternative glycemic markers:

    • Fructosamine or glycated albumin can be used to assess glycemic control over 2-3 weeks 2, 4
    • Continuous glucose monitoring (CGM) provides detailed glycemic patterns and can calculate estimated A1c 1, 2
    • Self-monitoring of blood glucose (SMBG) can help validate HbA1c results 1

Important Caveats and Pitfalls

  • Laboratory Notification: Inform the laboratory about the presence of HbE trait when ordering HbA1c tests

  • Regular Monitoring: For patients with known HbE trait, consistent use of the same laboratory method is important for reliable trend monitoring

  • Method Switching: Changing between different assay methods may result in apparent changes in HbA1c that do not reflect actual changes in glycemic control

  • Documentation: Document the presence of HbE trait in the patient's medical record to ensure appropriate interpretation of HbA1c results

  • Comprehensive Assessment: Use multiple methods to assess glycemic control when HbA1c reliability is questionable 2

By understanding these considerations, clinicians can appropriately interpret HbA1c results in patients with HbE trait and make informed decisions about diabetes management to optimize patient outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Management of Diabetes in Patients with Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.